These NSE stocks hit their 52-week highs or lows on July 2

SUMMARY

The Indian market was trading lower around noon on Tuesday as auto stocks declined after reporting disappointing June sales data. However, the markets pared losses and are currently in the green. At 2.50 PM, the BSE Sensex was up 88.61 points, or 0.22 percent, at 39,775.11, and the Nifty 50 was trading 28.45 points, or 0.24 percent, higher at 11,894.05. While stocks such as Adani Power, HDFC Bank, SBI Life Insurance rose to reach their 52-week high, Cox & Kings and Ruchi Soya hit their 52-week low today.

By CNBC-TV18Jul 2, 2019 3:09:16 PM IST (Published)

Adani Power rose 7.3 percent to hit its 52-week high of Rs 64.70 per share. The company acquired GMR Chhattisgarh Energy Ltd as the consortium of lenders approved its resolution plan, according to an exchange filing.

HDFC rose 1.4 percent to touch the 52-week high of Rs 2277.60 per share on NSE.

HDFC Bank climbed 0.2 percent to touch the 52-week high of Rs 2495 per share.

Torrent Power rose one percent to hit the 52-week high of Rs 293.45 per share. The company acquired GMR Chhattisgarh Energy Ltd as the consortium of lenders approved its resolution plan, according to an exchange filing.

SBI Life Insurance rose 2.3 percent to reach its 52-week high of Rs 752.70 per share on the NSE.

Eros Media fell 4.9 percent to touch its 52-week low of Rs 16.35 per share on the NSE. Earlier this month, the company was downgraded by CARE Ratings and Moody's Investors Service, resulting in the decline of the stock.

Ruchi Soya shares lost 4.9 percent to hit the 52-week low of Rs 4.85 per share on the NSE.

TVS Motor Company shed 2.6 percent to hit the 52-week low of Rs 424 per share. The company registered sales of 2,97,102 units in June 2019, as against 3,13,614 units in the same month a year ago, with sales slipping 6.26 percent amid a slowdown in the automobile industry.

Glenmark Pharma fell about 0.7 percent to reach the 52-week low of Rs 438.10 per share. The company said that it has received US FDA approval for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood.

Cox & Kings declined 5 percent to touch the 52-week low of Rs 33.25 per share on the NSE. The company defaulted on another commercial paper worth Rs 50 crore, citing temporary mismatch in liquidity.